• Allergan Textured Implant Lawsuit Settlement

    Published On: December 10, 2024|Categories: Breast Implant|By |

    In 2019, Allergan, one of the largest manufacturers of breast implants, faced multiple lawsuits due to its textured implants being linked to BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma). The company ultimately agreed to settle the claims for over $3 billion. This breast implant settlement covered thousands of women who had developed BIA-ALCL or suffered other complications, such as implant rupture or chronic pain. 

    Many victims were compensated for their medical treatment, surgeries to remove the implants, and legal fees. The settlement also provided for ongoing medical monitoring for affected individuals. This case set a significant example, highlighting the potential for substantial financial relief for those harmed by dangerous products.

  • Johnson & Johnson Settlement

    Published On: December 10, 2024|Categories: Breast Implant|By |

    Johnson & Johnson, another leading breast implant manufacturer, faced lawsuits over the risks associated with its implants. In 2019, the company agreed to a $100 million settlement with women who suffered from complications such as implant rupture, infections, and other health issues. The settlement provided compensation for medical costs related to corrective surgeries, follow-up treatments, and the physical and emotional distress caused by the complications. 

    In addition to medical damages, the settlement included financial support for the psychological and emotional trauma endured by many victims who were unaware of the risks posed by the implants. This case underscored the importance of holding manufacturers accountable for failing to adequately inform patients about potential dangers.

  • Breast Implant Class Action Settlement

    Published On: December 10, 2024|Categories: Breast Implant|By |

    A class action lawsuit was filed against several breast implant manufacturers, accusing them of failing to adequately warn patients about the risks of implants, including rupture, chronic pain, and the development of Breast Implant Illness (BII). The lawsuit resulted in a $50 million settlement in 2020, which aimed to compensate victims for the physical, emotional, and financial damages caused by the implants. 

    Victims of this class action were provided funds to help cover the costs of implant removal, corrective surgeries, and ongoing medical care. The settlement also offered compensation for pain, suffering, and the loss of quality of life. This case highlighted the importance of transparency in the medical device industry and the need for manufacturers to provide clear warnings about potential health risks.